跳至主要内容
临床试验/TCTR20211213004
TCTR20211213004尚未招募不适用

Incidence of active tuberculosis in latent tuberculosis infection end stage kidney disease patients waiting for kidney transplant treated with isoniazid and rifapentine 1 month

Division of nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 260 人开始时间: 2021年12月13日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Age >= 18 years old
  • 2. Normal chest X-ray within 90 days
  • 3. Body weight >= 35 kg
  • 4. Laboratory investigations revealed
  • - AST and ALT < 3 x ULN
  • - Total bilirubin < 1.5 mg/d

排除标准

  • 1. Has sign or symptoms of active tuberculosis
  • 2. During treatment of active tuberculosis
  • 3. History of active tuberculosis treatment within 2 years
  • 4. History of latent tuberculosis treatment within 2 years
  • 5. History of isoniazid or rifampicin/rifapentine resistace
  • 6. Cirrhosis
  • 7 . Pregnancy or during breast feeding
  • 8. HIV infection

研究者

发起方
Division of nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University

相似试验